Clinical trial IJB-MULTI-MIME-A-2017
IJB-MULTI-MIME-A-2017 Multiorgan Metabolic imaging response assessment of Abemaciclib: the MiMe-A trial
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Oui |
| Sponsor | Institut Jules Bordet |
| EudraCT Identifier | 2017-000123-28 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03339843 |
| Inclusion criteria | Metastatic or non-resecable. Refractory to platinum regimen |
| Last update |